M.A. Egea

2.7k total citations
40 papers, 2.2k citations indexed

About

M.A. Egea is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, M.A. Egea has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmaceutical Science, 12 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in M.A. Egea's work include Advancements in Transdermal Drug Delivery (19 papers), Advanced Drug Delivery Systems (19 papers) and Drug Solubulity and Delivery Systems (13 papers). M.A. Egea is often cited by papers focused on Advancements in Transdermal Drug Delivery (19 papers), Advanced Drug Delivery Systems (19 papers) and Drug Solubulity and Delivery Systems (13 papers). M.A. Egea collaborates with scholars based in Spain, Portugal and France. M.A. Egea's co-authors include María L. García, Eliana B. Souto, Elisabet González‐Mira, Ana Cristina Calpena, Joana Araújo, E. Vega, Joana F. Fangueiro, Amélia M. Silva, Marta Espina and Tatiana Andreani and has published in prestigious journals such as Langmuir, Journal of Colloid and Interface Science and Inorganic Chemistry.

In The Last Decade

M.A. Egea

40 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Egea Spain 23 1.4k 556 460 360 299 40 2.2k
Susi Burgalassi Italy 29 1.4k 1.0× 469 0.8× 779 1.7× 284 0.8× 310 1.0× 87 2.6k
Daniela Monti Italy 29 994 0.7× 433 0.8× 472 1.0× 188 0.5× 212 0.7× 99 2.3k
Samar Mansour Egypt 30 1.6k 1.2× 661 1.2× 330 0.7× 489 1.4× 283 0.9× 61 2.8k
Mohamed A. El-Nabarawi Egypt 29 2.0k 1.4× 537 1.0× 340 0.7× 420 1.2× 311 1.0× 168 3.1k
Hamdy Abdelkader Egypt 27 1.2k 0.9× 502 0.9× 536 1.2× 257 0.7× 118 0.4× 78 2.2k
Mohd Abul Kalam Saudi Arabia 26 908 0.6× 558 1.0× 457 1.0× 366 1.0× 191 0.6× 88 2.1k
Slavomíra Doktorovová Portugal 24 1.2k 0.8× 823 1.5× 213 0.5× 351 1.0× 477 1.6× 36 2.3k
Neslihan Üstündağ Okur Türkiye 22 993 0.7× 295 0.5× 340 0.7× 473 1.3× 236 0.8× 98 2.1k
Nahed D. Mortada Egypt 31 2.1k 1.5× 791 1.4× 388 0.8× 564 1.6× 365 1.2× 65 3.5k
Elisabet González‐Mira Spain 15 1.0k 0.7× 455 0.8× 276 0.6× 178 0.5× 240 0.8× 17 1.5k

Countries citing papers authored by M.A. Egea

Since Specialization
Citations

This map shows the geographic impact of M.A. Egea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Egea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Egea more than expected).

Fields of papers citing papers by M.A. Egea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Egea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Egea. The network helps show where M.A. Egea may publish in the future.

Co-authorship network of co-authors of M.A. Egea

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Egea. A scholar is included among the top collaborators of M.A. Egea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Egea. M.A. Egea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fangueiro, Joana F., Ana Cristina Calpena, Beatriz Clares, et al.. (2016). Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo , in vitro and ex vivo studies. International Journal of Pharmaceutics. 502(1-2). 161–169. 108 indexed citations
2.
Parra, Alexander, Mireia Mallandrich, Beatriz Clares, et al.. (2015). Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications. Colloids and Surfaces B Biointerfaces. 136. 935–943. 39 indexed citations
3.
Fangueiro, Joana F., Alexander Parra, Amélia M. Silva, et al.. (2014). Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate. International Journal of Pharmaceutics. 475(1-2). 181–190. 45 indexed citations
4.
Fangueiro, Joana F., Tatiana Andreani, M.A. Egea, et al.. (2013). Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity. International Journal of Pharmaceutics. 461(1-2). 64–73. 121 indexed citations
5.
Fangueiro, Joana F., Tatiana Andreani, M.A. Egea, et al.. (2012). Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process. Colloids and Surfaces B Biointerfaces. 100. 84–89. 56 indexed citations
6.
Silva, Ana Catarina, Elisabet González‐Mira, María L. García, et al.. (2011). Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound. Colloids and Surfaces B Biointerfaces. 86(1). 158–165. 231 indexed citations
7.
Araújo, Joana, et al.. (2011). Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids and Surfaces B Biointerfaces. 88(1). 150–157. 136 indexed citations
8.
González‐Mira, Elisabet, M.A. Egea, Eliana B. Souto, Ana Cristina Calpena, & María L. García. (2010). Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology. 22(4). 45101–45101. 144 indexed citations
9.
González‐Mira, Elisabet, M.A. Egea, María L. García, & Eliana B. Souto. (2010). Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids and Surfaces B Biointerfaces. 81(2). 412–421. 170 indexed citations
10.
Araújo, Joana, E. Vega, Carla M. Lopes, et al.. (2009). Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids and Surfaces B Biointerfaces. 72(1). 48–56. 127 indexed citations
11.
12.
Valls, Rosa M., et al.. (2008). Transcorneal Permeation in a Corneal Device of Non-Steroidal Anti-Inflammatory Drugs in Drug Delivery Systems. PubMed. 2(1). 66–71. 33 indexed citations
13.
Valls, Rosa M., María L. García, M.A. Egea, & Oriol T. Valls. (2008). Validation of a device for transcorneal drug permeation measure. Journal of Pharmaceutical and Biomedical Analysis. 48(3). 657–663. 4 indexed citations
14.
Vega, E., M.A. Egea, Oriol T. Valls, Marta Espina, & María L. García. (2006). Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration. Journal of Pharmaceutical Sciences. 95(11). 2393–2405. 102 indexed citations
15.
Egea, M.A., et al.. (2004). Stability and ocular tolerance of cyclophosphamide-loaded nanospheres. Journal of Microencapsulation. 21(2). 213–223. 8 indexed citations
16.
Espina, Marta, et al.. (2002). Cyclophosphamide-loaded nanospheres: analysis of the matrix structure by thermal and spectroscopic methods. Journal of Microencapsulation. 19(3). 305–310. 12 indexed citations
17.
Egea, M.A., et al.. (1999). An inductively coupled plasma method for determination of cyclophosphamide loaded to polymeric systems. Journal of Pharmaceutical and Biomedical Analysis. 21(3). 611–618. 5 indexed citations
18.
Chauvet, Alain, et al.. (1999). Stability and In Vitro Drug Release of Flurbiprofen-Loaded Poly-ε-Caprolactone Nanospheres. Drug Development and Industrial Pharmacy. 25(9). 983–993. 31 indexed citations
19.
20.
Egea, M.A., María L. García, M. A. Alsina, & Fergus Reig. (1994). Coating of Liposomes with Transferrin: Physicochemical Study of the Transferrin-Lipid System. Journal of Pharmaceutical Sciences. 83(2). 169–173. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susi Burgalassi Breakdown of academic impact, for papers by Daniela Monti Breakdown of academic impact, for papers by Samar Mansour Breakdown of academic impact, for papers by Mohamed A. El-Nabarawi Breakdown of academic impact, for papers by Hamdy Abdelkader Breakdown of academic impact, for papers by Mohd Abul Kalam Breakdown of academic impact, for papers by Slavomíra Doktorovová Breakdown of academic impact, for papers by Neslihan Üstündağ Okur Breakdown of academic impact, for papers by Nahed D. Mortada Breakdown of academic impact, for papers by Elisabet González‐Mira
Rankless by CCL
2026